Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Marts 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.5k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #126

    i think that could be a fair comment, maybe even a Q&A question; could they have guided better /earlier about those investments

    1 Reply Last reply
    0
    • Legolas23L Offline
      Legolas23L Offline
      Legolas23
      wrote on sidst redigeret af
      #127

      Jeg tænker, det er logisk nok, at Genmab skal forsøge at få deres pipeline på markedet så hurtigt som muligt for at blive et powerhouse med stor vækst og udvikling. Det koster og skal man nå markedet med

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #128

        But Jan has been very vocal in that he wanted a 'military style'
        development

        1 Reply Last reply
        0
        • Legolas23L Offline
          Legolas23L Offline
          Legolas23
          wrote on sidst redigeret af
          #129

          mens man har produkterne, så kræver det man smeder mens jernet er varmt.

          1 Reply Last reply
          0
          • Legolas23L Offline
            Legolas23L Offline
            Legolas23
            wrote on sidst redigeret af
            #130

            I min optik kunne de ikke guide ret meget anerledes. Måske var det derfor de iværksatte tilbagekøb af aktier for at dæmme op for kursen ville dykke for meget. Det er nu sket, hvilket bør være en god mulighed for nye investorer at købe sig billigt ind i casen.

            1 Reply Last reply
            0
            • Legolas23L Offline
              Legolas23L Offline
              Legolas23
              wrote on sidst redigeret af
              #131

              TA er et fint redskab til at vise psykologien i markedet, men det kan ikke stå alene i biotek. Der skal casen være nummer et og de ting man nogenlunde ved kommer eller som genmab skal give opdatering på. De TA charts, som har været præsenteret har jeg ikke kunne bruge til ret meget. Det viser en udvilking, som er sket. Hvad der kommer ved kun Genmab. På med de lange briller...

              1 Reply Last reply
              0
              • S Offline
                S Offline
                Sukkeralf
                wrote on sidst redigeret af
                #132

                With epcoritamab i kind of gives itself - either they put in a lot of money and try to keep up with Roche or they dont do it at all

                1 Reply Last reply
                0
                • S Offline
                  S Offline
                  Sukkeralf
                  wrote on sidst redigeret af
                  #133

                  With the BsAb checkpointinhibitor they could moved ahead a bit slower but here is the oppertunity perhaps even bigger so fine with me that they also speed this up

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #134

                    you know what
                    , that is exactly how i see it...

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #135

                      The whole of last year I have been hoping for speed on specially the Epcoritamab trials, worrying the pandemic might slow things down and getting further behind the competion. I am getting that speed now, so to me this is a plus.

                      1 Reply Last reply
                      0
                      • Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktør
                        wrote on sidst redigeret af
                        #136

                        Just a moment...

                        favicon

                        (www.proinvestor.com)

                        1 Reply Last reply
                        0
                        • S Offline
                          S Offline
                          Sukkeralf
                          wrote on sidst redigeret af
                          #137

                          And I totally disagree with TheNote - JAn for sure knows how to run GEnmab better than the investors......so a better guidance earlier must be the solution forward

                          1 Reply Last reply
                          0
                          • S Offline
                            S Offline
                            Sukkeralf
                            wrote on sidst redigeret af
                            #138

                            E L we have already seen that sc dosing with Darzalex is a big advantage - specially in these pandemic times. Words say the same thing about Kesimpta. So that really a good card to have with epcoritamab even though we hopefully are more or less out of this sick Corona times when we get an approval.

                            1 Reply Last reply
                            0
                            • DarvinD Offline
                              DarvinD Offline
                              Darvin
                              wrote on sidst redigeret af
                              #139

                              Asolut og aldeles enig med Bioshare, E L, Sukkeralf, GeorgeBest m.fl. Og som E L skriver så har Jan egentlig advaret længe om at de ville sætte alt ind mit udvikling

                              1 Reply Last reply
                              0
                              • troldmandenT Offline
                                troldmandenT Offline
                                troldmanden
                                wrote on sidst redigeret af
                                #140

                                Det er faktisk en stor bøf fra deres IR afdelinges side. Det er dem der skal hjælpe med at guide analytikerne. Indikere at de har sat udgiftsnivauet lavere end hvad det bliver. Jan har jo ikke misset en mulighed for i starte at sige igen og igen at analytikerne havde sat dara topsalg for lavt. Derved opjusterede en masse analytikere. Det skal de altså også sørge for når det går den anden vej

                                1 Reply Last reply
                                0
                                • troldmandenT Offline
                                  troldmandenT Offline
                                  troldmanden
                                  wrote on sidst redigeret af
                                  #141

                                  Så det er en fejl 40. De er selv skyld i markedet var SÅ meget forkert på den

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #142

                                    Plesner really had a few interesting observations in his article by the way, eg on treating early, using the best treatment upfront or how long to (re-)treat

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #143

                                      Genmab keeping dates for GEN1046 in clinicaltrials as they were , just adding a few trial sites, so no reason to worry about Covid delays
                                      for now https://clinicaltrials.gov/ct2/history/NCT03917381?A=11&B=12&C=merged#StudyPageTop

                                      1 Reply Last reply
                                      0
                                      • D Offline
                                        D Offline
                                        Doublo
                                        wrote on sidst redigeret af
                                        #144

                                        Legolas det er der sikkert også nogen der gerne vil, men hvornår når vi bunden, det er spørgsmålet. Et langt stykke hen ad vejen kan man supplere når aktien falder, men mellem 50 og 100 kurspoint om dagen i uger, kan man ikke køber sig ud af. Jeg har snar så mange, at jeg må lade mig registrere som storaktionær, overdrivelse kan forekomme.

                                        1 Reply Last reply
                                        0
                                        • K Offline
                                          K Offline
                                          Klarussen
                                          wrote on sidst redigeret af
                                          #145

                                          En faldende kniv må man sige...

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger